Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmond A Knopp

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Technology in Cancer Research & Treatment|November 25, 2004
Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imagingMeng Law, Micole Hamburger, Glyn Johnson, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 13, 2006
Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR systemDarren B Orbach, Chris Wu, Meng Law, et al.
Journal of Pediatric Hematology/Oncology|May 22, 2003
Temozolomide is active in childhood, progressive, unresectable, low-grade gliomasDennis J Kuo, Howard L Weiner, Jeffrey Wisoff, et al.
AJR. American Journal of Roentgenology|July 24, 2015
Cerebral Peduncle Angle: An Objective Criterion for Assessing Progressive Supranuclear Palsy Richardson SyndromeGirish M Fatterpekar, August Dietrich, Patrizia Pantano, et al.
Magnetic Resonance Imaging|June 3, 2004
Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in gangliogliomaMeng Law, Daniel E Meltzer, Stephan G Wetzel, et al.
AJNR. American Journal of Neuroradiology|November 20, 2003
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imagingMeng Law, Stanley Yang, Hao Wang, et al.
Radiology|January 7, 2006
Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical responseMeng Law, Sarah Oh, James S Babb, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2014
Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous systemJuan E Gutierrez, Martin Rosenberg, Michael Duhaney, et al.
AJNR. American Journal of Neuroradiology|September 19, 2003
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomasStanley Yang, Meng Law, David Zagzag, et al.
AJNR. American Journal of Neuroradiology|June 14, 2002
Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examinationStephan G Wetzel, Glyn Johnson, Andrew G S Tan, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Technology in Cancer Research & Treatment|November 25, 2004
Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imagingMeng Law, Micole Hamburger, Glyn Johnson, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 13, 2006
Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR systemDarren B Orbach, Chris Wu, Meng Law, et al.
Journal of Pediatric Hematology/Oncology|May 22, 2003
Temozolomide is active in childhood, progressive, unresectable, low-grade gliomasDennis J Kuo, Howard L Weiner, Jeffrey Wisoff, et al.
AJR. American Journal of Roentgenology|July 24, 2015
Cerebral Peduncle Angle: An Objective Criterion for Assessing Progressive Supranuclear Palsy Richardson SyndromeGirish M Fatterpekar, August Dietrich, Patrizia Pantano, et al.
Magnetic Resonance Imaging|June 3, 2004
Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in gangliogliomaMeng Law, Daniel E Meltzer, Stephan G Wetzel, et al.
AJNR. American Journal of Neuroradiology|November 20, 2003
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imagingMeng Law, Stanley Yang, Hao Wang, et al.
Radiology|January 7, 2006
Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical responseMeng Law, Sarah Oh, James S Babb, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 1, 2014
Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous systemJuan E Gutierrez, Martin Rosenberg, Michael Duhaney, et al.
AJNR. American Journal of Neuroradiology|September 19, 2003
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomasStanley Yang, Meng Law, David Zagzag, et al.
AJNR. American Journal of Neuroradiology|June 14, 2002
Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examinationStephan G Wetzel, Glyn Johnson, Andrew G S Tan, et al.
Pageof 3